This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

PAUL A. CHANDLER, M.D.

AMA Arch Ophthalmol. 1957;57(5):639-643.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Since the discovery^1,2 that the carbonicanhydrase-inhibiting drug acetazoleamide (Diamox) brings about a lowering of the intraocular pressure, its use has been widespread in the treatment of glaucoma. Its pressure-lowering effect is due solely to a lessening of the rate of aqueous production. The obstruction to outflow of aqueous is uninfluenced by acetazoleamide. Thus the use of this drug in the treatment of glaucoma must be regarded as a palliative treat ment, since it in no way affects the fundamental cause of increased intraocular pressure—obstruction to outflow. Such palliative treatment is often of tremendous value in preventing damage to vision while other measures are employed to relieve the fundamental difficulty—obstruction to outflow of aqueous. This principle is employed in other ophthalmological problems. Thus the use of steroids in certain inflammatory ocular conditions, while not affecting the fundamental disease process, may lessen the inflammatory manifestations and protect the eye from irreparable . . . [Full Text PDF of this Article]

Author Affiliations
Boston

Footnotes
Received for publication Jan. 7, 1957.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?